In support, IL-4, IL-5, and IL-10 have previously been shown to increase over the course of disease in patients with severe COVID-19 [7, 38], suggesting an extensive upregulation of the adaptive immunity during COVID-19 [13]. This evidence concerns the gene IL10 and COVID-19.